The Molecular Tumor Board (MTB) is comprised of a group of experts that reviews and interprets molecular findings. For information about how to attend the weekly Molecular Tumor Board meetings, please contact Michelle Turski, PhD.
Alejandro Sweet-Cordero, MD, Professor of Pediatrics (Hematology/Oncology), Director of the Molecular Oncology Initiative.
Eric Collisson, MD, Associate Professor of Medicine (Hematology/Oncology), Molecular Tumor Board Discussant and Advisor.
Mallika Dhawan, MD, Assistant Professor of Medicine (Hematology/Oncology), Medical Director of Cancer Genetics Prevention Program and Hereditary Cancer Clinic.
Jennifer Grabowsky, PharmD, Oncology Pharmacist, Molecular Tumor Board Discussant and Advisor.
Mark Moasser, MD, Professor of Medicine (Hematology/Oncology), Molecular Tumor Board Discussant and Advisor.
Adam Olshen, PhD, Professor of Epidemiology and Biostatistics, Director of Computational Biology and Informatics Core, Molecular Oncology Initiative Technical Advisor.
Marta Sabbadini PhDMS, Genetic Counselor, UCSF.
Jessica Schulte, MD, PhD, Neuro-Oncologist, Molecular Tumor Board Discussant and Advisor.
Elliot Stieglitz, MD, Assistant Professor of Pediatrics (Hematology/Oncology), Molecular Tumor Board Discussant and Advisor.
Beth Apsel Winger, MD, PhD, Assistant Professor of Pediatrics (Hematology/Oncology), Molecular Tumor Board Discussant and Advisor.
